KRMD
Income statement / Annual
Last year (2024), KORU Medical Systems, Inc.'s total revenue was $33.65 M,
an increase of 17.98% from the previous year.
In 2024, KORU Medical Systems, Inc.'s net income was -$6.07 M.
See KORU Medical Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
02/28/2017 |
02/29/2016 |
| Operating Revenue |
$33.65 M |
$28.52 M |
$27.90 M |
$23.49 M |
$24.18 M |
$23.16 M |
$17.35 M |
$15.98 M |
$12.29 M |
$12.25 M |
| Cost of Revenue |
$12.31 M
|
$11.81 M
|
$12.53 M
|
$9.72 M
|
$9.24 M
|
$8.31 M
|
$6.54 M
|
$6.52 M
|
$4.72 M
|
$4.64 M
|
| Gross Profit |
$21.33 M
|
$16.71 M
|
$15.37 M
|
$13.77 M
|
$14.94 M
|
$14.85 M
|
$10.81 M
|
$9.46 M
|
$7.57 M
|
$7.60 M
|
| Gross Profit Ratio |
0.63
|
0.59
|
0.55
|
0.59
|
0.62
|
0.64
|
0.62
|
0.59
|
0.62
|
0.62
|
| Research and Development Expenses |
$5.26 M
|
$5.74 M
|
$4.96 M
|
$2.47 M
|
$1.30 M
|
$740.48 K
|
$241.12 K
|
$60.70 K
|
$237.49 K
|
$207.28 K
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.77 M
|
$8.20 M
|
$7.91 M
|
$7.77 M
|
$5.94 M
|
| Other Expenses |
$22.52 M
|
$21.24 M
|
$21.19 M
|
$18.33 M
|
$14.89 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$9.20 K
|
| Operating Expenses |
$27.78 M
|
$26.98 M
|
$26.15 M
|
$20.80 M
|
$16.19 M
|
$10.85 M
|
$8.75 M
|
$7.97 M
|
$8.31 M
|
$6.42 M
|
| Cost And Expenses |
$40.09 M
|
$38.79 M
|
$38.68 M
|
$30.52 M
|
$25.43 M
|
$19.16 M
|
$15.29 M
|
$14.49 M
|
$13.03 M
|
$11.07 M
|
| Interest Income |
$444.64 K
|
$561.33 K
|
$145.59 K
|
$13.08 K
|
$42.40 K
|
$80.66 K
|
$28.10 K
|
$0.00
|
$2.94 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.89 K
|
$3.41 K
|
| Depreciation & Amortization |
$772.89 K
|
$870.39 K
|
$587.14 K
|
$463.13 K
|
$418.60 K
|
$340.23 K
|
$309.26 K
|
$308.71 K
|
$300.61 K
|
$271.57 K
|
| EBITDA |
-$5.67 M |
-$9.40 M |
-$10.19 M |
-$6.57 M |
$1.61 M |
$4.34 M |
$2.37 M |
$1.88 M |
-$474.20 K |
$1.42 M |
| EBITDA Ratio |
-0.17
|
-0.33
|
-0.37
|
-0.28
|
0.07
|
0.19
|
0.14
|
0.12
|
-0.04
|
0.12
|
| Operating Income Ratio |
-0.19
|
-0.36
|
-0.39
|
-0.3
|
-0.05
|
0.03
|
0.07
|
0.09
|
-0.06
|
0.1
|
| Total Other Income/Expenses Net |
$382.49 K
|
$496.40 K
|
$105.71 K
|
$665.09 K
|
$60.52 K
|
$110.74 K
|
$12.41 K
|
$85.18 K
|
-$40.45 K
|
-$38.81 K
|
| Income Before Tax |
-$6.06 M
|
-$9.77 M
|
-$10.68 M
|
-$6.36 M
|
-$1.19 M
|
$696.42 K
|
$1.18 M
|
$1.57 M
|
-$776.70 K
|
$1.14 M
|
| Income Before Tax Ratio |
-0.18
|
-0.34
|
-0.38
|
-0.27
|
-0.05
|
0.03
|
0.07
|
0.1
|
-0.06
|
0.09
|
| Income Tax Expense |
$2.89 K
|
$3.97 M
|
-$2.01 M
|
-$1.80 M
|
$17.80 K
|
$132.07 K
|
$266.38 K
|
$483.08 K
|
-$241.70 K
|
$359.71 K
|
| Net Income |
-$6.07 M
|
-$13.74 M
|
-$8.66 M
|
-$4.56 M
|
-$1.21 M
|
$564.35 K
|
$910.57 K
|
$1.09 M
|
-$535.00 K
|
$782.86 K
|
| Net Income Ratio |
-0.18
|
-0.48
|
-0.31
|
-0.19
|
-0.05
|
0.02
|
0.05
|
0.07
|
-0.04
|
0.06
|
| EPS |
-0.13 |
-0.3 |
-0.19 |
-0.1 |
-0.0289 |
0.0146 |
0.0239 |
0.0287 |
-0.0141 |
0.02 |
| EPS Diluted |
-0.13 |
-0.3 |
-0.19 |
-0.1 |
-0.0289 |
0.0144 |
0.0234 |
0.0283 |
-0.0141 |
0.02 |
| Weighted Average Shares Out |
$45.80 M
|
$45.60 M
|
$45.00 M
|
$44.39 M
|
$41.93 M
|
$38.78 M
|
$38.13 M
|
$37.87 M
|
$37.83 M
|
$37.99 M
|
| Weighted Average Shares Out Diluted |
$45.80 M
|
$45.60 M
|
$45.00 M
|
$44.39 M
|
$41.93 M
|
$39.06 M
|
$38.92 M
|
$38.39 M
|
$37.88 M
|
$37.99 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
